MML Investors Services
NVCR icon

MML Investors Services’s NovoCure NVCR Stock Holding History

MML Investors Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,302
Closed -$242K – 2203
2022
Q4 		$242K Buy
3,302
+340
+11% +$25.6K ﹤0.01% 1914
2022
Q3 		$225K Buy
+2,962
New +$231K ﹤0.01% 1864
2022
Q2 		– Sell
-4,032
Closed -$334K – 2102
2022
Q1 		$334K Sell
4,032
-586
-13% -$43.2K ﹤0.01% 1656
2021
Q4 		$347K Buy
4,618
+424
+10% +$42.6K ﹤0.01% 1615
2021
Q3 		$487K Buy
4,194
+542
+15% +$81.9K ﹤0.01% 1371
2021
Q2 		$810K Buy
3,652
+1,206
+49% +$235K 0.01% 1092
2021
Q1 		$323K Sell
2,446
-8
-0.3% -$1.26K ﹤0.01% 1476
2020
Q4 		$425K Buy
+2,454
New +$336K ﹤0.01% 1244

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

MML Investors Services's NVCR Position: Q1 2023 in Review

MML Investors Services sold out of NovoCure (NVCR) in Q1 2023, closing a stake of 3,302 shares — an estimated $242K sold.

MML Investors Services first reported a position in NVCR in Q4 2020 and held it in 8 quarters. The position peaked at $810K in Q2 2021. 295 funds tracked by Wall St. Rank hold NVCR as of Q1 2023.

  • MML Investors Services reported no remaining NovoCure position as of Q1 2023 after selling out during the quarter.
  • MML Investors Services sold 3,302 NovoCure shares in Q1 2023, an estimated $242K.
  • MML Investors Services first reported a position in NovoCure in Q4 2020 and held it in 8 quarters.
  • MML Investors Services's NovoCure position peaked at $810K in Q2 2021.
  • 295 funds tracked by Wall St. Rank held NovoCure as of Q1 2023.

Based on MML Investors Services's 13F filing for Q1 2023, filed 12 May 2023.